Skip to main content
OpenTrials

Clinical trial condition

Primary Peritoneal Carcinoma

Explore clinical trials studying Primary Peritoneal Carcinoma. Study availability and eligibility vary by location and protocol.

102 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Primary Peritoneal Carcinoma trial results

Completed

Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer

NCT04406623

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • City of Hope Duarte, California, United States
  • START Midwest Grand Rapids, Michigan, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Stephenson Cancer Center at Oklahoma University Oklahoma City, Oklahoma, United States
View Trial Details
Completed

Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)

NCT03648489

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +22 more
Locations
  • Charité Universitätsmedizin Berlin Berlin, Germany
  • Universitätsklinikum Carl Gustav Carus Dresden Dresden, Germany
  • KEM Kliniken Essen-Mitte Essen, Germany
  • Furness General Hospital Barrow in Furness, Cumbria, United Kingdom
View all 15 locations
View Trial Details
Completed

Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial

NCT01506856

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
  • Queen Mary Hospital Hong Kong, High West
  • Aichi Cancer Center Hospital Chikusa, Aichi-ken, Japan
  • Hirosaki University School of Medicine & Hospital Hirosaki-shi, Aomori, Japan
View all 62 locations
View Trial Details
Completed

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

NCT03602079

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +129 more
Locations
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • Beth Israel Deaconess Medical Center Cancer Center Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Clinical Research Alliance, Inc. Lake Success, New York, United States
View Trial Details
Completed

A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies

NCT04440943

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Urothelial Carcinoma, +61 more
Locations
  • Northside Hospital Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States
  • Duke Cancer Center Durham, North Carolina, United States
View Trial Details
Completed

Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies

NCT01974765

Conditions
Advanced Epithelial Ovarian, Fallopian Tube, Primary Peritoneal Carcinoma, +1 more
Locations
  • Memorial Sloan Kettering Cancer Center at Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
View Trial Details
Completed

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

NCT03849469

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Solid Tumors, +108 more
Locations
  • UCSD Medical Center - Encinitas Encinitas, California, United States
  • Koman Family Outpatient Pavilion La Jolla, California, United States
  • UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion) La Jolla, California, United States
  • UCSD Altman Clinical and Translational Research Institute Building (ACTRI) La Jolla, California, United States
View all 28 locations
View Trial Details

Related conditions